Novo Nordisk A/S (NVO) P/FCF 36.1 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Novo Nordisk A/SNVO

$50.32

-$1.16 (-2.253%)

at close

$50.33

$0.0055 (0.011%)

after hours · 11:59 PM

4.04/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

NVO

Stock Profile

Showing data forNOVO B.CO

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Showing data forNOVO B.CO

Explore Scores Tab

4.04

Good

Novo Nordisk A/S has grown revenue at 8.13% over the past year, which suggests sales are increasing. Also, it has seen its net income increase by 16.58% over the past year, which suggests its profits are growing at a strong rate.

Valuation Score

Key Score

3.00

Average

Management

4.00

Good

Growth

4.00

Good

Profitability

4.00

Good

Fin. Health

1.00

Very Bad

Dividends

2.00

Bad

Analyst

4.00

Good

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Insufficient Insider data to display this section

Peers

Select stocks to compare

HLUN A.COH Lundbeck A/s

DKK 36.70

+0.82%

ALK B.COAlk-Abello A/s

DKK 240.00

-1.07%

PEG.COPharma Equity Group A/s

DKK 0.09

+4.88%

STENO.COStenocare A/s

DKK 1.01

+3.06%

NOVO B.CONovo Nordisk A/s

DKK 329.90

-1.76%

Price Targets & Ratings

View Analysis

1-year price targets, ending Jun 30, 2027

Current

$50.32

Baseline

High

$73.18

▲

45.42%

Avg

$51.19

▲

1.73%

Low

$31.01

▼

-38.38%

Analyst Ratings based on 37 Analysts

Strong Buy

14%

Buy

22%

Hold

59%

Sell

03%

Strong Sell

03%

About

Stock News

View All Updates